探讨脑活素对新生儿缺氧缺血性脑病的治疗效果，在常规治疗的基础上加用脑活素治疗８７例患儿，有效率为９１．９５％，与常规治疗８７例患儿有效率７４．７１％比较，差异有极显著意义（Ｐ＜０．０１）。轻、中、重度患儿脑活素治疗的有效率分别为９５．４５％、９３．６２％和８３．３３％，３者之间差异无显著意义（Ｐ＞０．０５）。结果表明脑活素对新生儿缺氧缺血性脑病轻中度有较好疗效，宜在临床进一步应用。 To investigate the therapeutic effect of cerebrolysin on neonatal hypoxic-ischemic encephalopathy, 87 patients were treated with cerebrolysin on the basis of routine treatment, the effective rate was 91.95%, compared with 87 cases of conventional treatment Efficiency 74.71%, the difference was significant (P <0.01). The effective rates of cerebrolysin in mild, moderate and severe children were 95.45%, 93.62% and 83.33%, respectively. There was no significant difference between the three groups (P> 0.05). The results show that cerebrolysin mild to moderate neonatal hypoxic-ischemic encephalopathy has a good effect, should be further clinical application.